Luoxin Pharmaceutical Group Co., LTD. (Stock code: 002793) is a prominent pharmaceutical enterprise group that engages in drug research and development, production, trade, and medical and health services. With five manufacturing bases and over 50 production lines, Luoxin focuses on providing a comprehensive array of pharmaceutical products. Key offerings include powder injection, lyophilized powder for injection, solid formulations, aerosols, pre-filled injections, and both chemical and cephalosporin APIs. This commitment to diversifying the pharmaceutical landscape reflects Luoxin's dedication to improving the health and well-being of individuals.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Contract Development and Manufacturing (CDMO)
- Powder Injection Manufacturing
- Lyophilized Powder for Injection
- Solid Formulations including Cephalosporins
- Aerosols and Sprays
- Pre-filled and Large-Capacity Injections
- Small-Capacity Injections
- Atomized Inhalation Products

Luoxin is dedicated to delivering quality pharmaceuticals while upholding strong social responsibility values. For more information, please visit luoxin.cn.